Skip to content 
GPSR
Compliance
For Book
Publishers
-
Regulatory Compliance Analyst | EU/UK Product Compliance & Risk Mitigation
Regulatory Compliance Analyst at Euverify with experience in EU and UK product safety requirements. Focused on risk assessments, technical file preparation, and regulatory mapping across diverse products. Brings a creative edge to compliance work, supported by a background in AI-driven research and analysis.
- January 9, 2026Regulatory FrameworkAmazon AHD Verification for E-Mobility Devices: Battery, Electrical & Testing Requirements (EU and UK)
- January 2, 2026Industry InsightsIVDs vs Medical Devices: How to Identify the Correct EU Regulatory Pathway
- December 19, 2025Regulatory FrameworkCE Marking Mistakes That Lead to Instant Product Withdrawals (EU & UK Compliance Guide)
- December 12, 2025Regulatory FrameworkUK Authorised Representative vs UK Responsible Person: The Complete Guide for Non-UK Manufacturers
IVDs vs Medical Devices: How to Identify the Correct EU Regulatory Pathway
Choosing the right regulatory pathway in the European Union is one of the most important decisions a medical technology company can make. Whether a product falls under the EU Medical Device Regulation (MDR) or the In Vitro Diagnostic Regulation (IVDR) shapes everything that comes next. This includes the conformity assessment process, evidence expectations, notified body involvement, timelines, costs, and long-term compliance responsibilities.
Even so, products are often misclassified, especially software, laboratory products, specimen-related tools, and systems that combine multiple components. This article breaks down how to tell the difference between IVDs and medical devices, explains how classification impacts EU compliance, and outlines what can happen when the wrong regulatory framework is used.
MDR vs IVDR: Key Differences and Compliance Requirements
In the EU, medical technologies are regulated under two separate but closely related rules:
- Regulation (EU) 2017/745 (MDR) for medical devices
- Regulation (EU) 2017/746 (IVDR) for in vitro diagnostic medical devices
Both frameworks share key principles such as risk-based classification, lifecycle oversight, post-market surveillance, and responsibilities for economic operators. Still, they are not interchangeable. A product can fall under only one regulation, based mainly on its intended purpose as defined by the manufacturer.
The distinction is legal, not commercial. How a product is marketed, branded, or sold does not determine whether MDR or IVDR applies.
Medical Device vs IVD: The Legal Definitions That Matter
What is a Medical Device under the MDR?
According to Article 2 of the MDR, a medical device is any instrument, apparatus, software, implant, reagent, material, or other article that a manufacturer intends to use for humans for purposes such as:
- Diagnosing, preventing, monitoring, predicting, treating, or alleviating disease
- Investigating, replacing, or modifying the anatomy or a physiological process
- Providing information through in vivo examination
Importantly, the MDR specifically excludes IVDs, which are regulated separately under the IVDR.
What is an In Vitro Diagnostic Medical Device under the IVDR?
Under Article 2 of the IVDR, an IVD is any device intended for the in vitro examination of specimens from the human body, such as blood, tissue, or other samples. These devices provide information about:
- A physiological or pathological condition
- A congenital abnormality
- The predisposition to a medical condition
- Compatibility with potential recipients, such as blood grouping
- Monitoring the effectiveness of therapeutic measures
The key difference is that IVDs do not act directly on the human body. Instead, they analyse samples outside the body to deliver diagnostic or clinical information.
How to Decide Whether MDR or IVDR Applies
The key factor is always the intended purpose, as described in the product’s instructions for use, labelling, and technical documentation.
In practical terms:
- If the product examines human specimens outside the body to provide medical information, it falls under the IVDR.
- If the product acts on or in the body, or supports diagnosis or treatment directly at the patient level, it falls under the MDR.
Some products can be borderline, including:
- Laboratory instruments used with IVD reagents
- Specimen collection devices
- Diagnostic software that processes lab data
- Systems that combine hardware, reagents, and software
For these cases, regulators expect manufacturers to document a clear and defensible classification rationale, often guided by MDCG recommendations on borderline products.
Why Classification Matters More Than Many Companies Expect
Once it is clear whether the MDR or IVDR applies, the next step is risk classification. This is where compliance requirements begin to differ in meaningful ways.
MDR Classification (Annex VIII)
Medical devices are divided into four risk classes:
- Class I, the lowest risk
- Class IIa
- Class IIb
- Class III, the highest risk
The classification is based on factors such as how long the device is used, whether it is invasive, where it is used in the body, and whether it has a diagnostic or therapeutic role.
IVDR Classification (Annex VIII)
IVDs are classified into four different classes:
- Class A, the lowest risk
- Class B
- Class C
- Class D, the highest risk
IVDR classification places strong emphasis on both individual patient risk and broader public health impact. This includes considering whether incorrect results could lead to death, serious deterioration in health, or wider public health consequences.
What Classification Changes in Practice
Classification affects several practical aspects of compliance, including:
- Whether a Notified Body is required
- The amount and type of evidence that must be generated
- The scope of the quality management system
- Post-market surveillance and vigilance obligations
- Review timelines and ongoing compliance costs
Under the IVDR, these changes are particularly significant. Many IVDs that were previously self-certified under the old IVD Directive now fall into Class B, C, or D, which means notified body involvement is required for the first time.
Compliance Obligations: MDR vs IVDR Compared
While the MDR and IVDR are structured in similar ways, their evidence expectations are quite different.
Evidence Requirements
Under the MDR, manufacturers must complete a clinical evaluation to show clinical safety and performance using clinical data.
The IVDR, by contrast, requires a performance evaluation. This includes:
- Scientific validity
- Analytical performance
- Clinical performance
These concepts are not interchangeable. Applying the wrong framework can invalidate a technical file.
Technical Documentation
Both regulations require detailed technical documentation, but they focus on different areas. The MDR emphasizes clinical benefit-risk, usability, and biological safety. The IVDR places greater emphasis on diagnostic accuracy, performance claims, and traceability to reference methods or materials.
Post-Market Obligations
Both the MDR and IVDR require manufacturers to have:
- Post-market surveillance plans
- Vigilance reporting processes
- Periodic safety update reports for higher-risk products
That said, the IVDR is more structured and prescriptive when it comes to post-market surveillance, especially for Class C and D IVDs.
What Happens If a Product Is Misclassified?
Misclassification is not a small administrative mistake. It is a regulatory non-compliance.
The consequences can include:
- Using the wrong conformity assessment route
- An invalid CE marking
- Rejection by importers or distributors
- Delays or refusals from notified bodies
- Corrective actions required by competent authorities
- Mandatory product withdrawal or recall
Both the MDR and IVDR require EU Member States to apply penalties that are effective, proportionate, and dissuasive when rules are breached. If a product is placed on the market under the wrong regulation or classification, enforcement action can follow.
From a business standpoint, misclassification often results in extensive rework. This may involve relabeling, revising intended purpose statements, repeating testing, and re-engaging with notified bodies.
When an EU Authorised Representative Is Required
If a manufacturer is not established in the European Union, they must appoint a single EU Authorised Representative to legally place MDR or IVDR products on the EU market.
This requirement applies equally to:
- Medical devices regulated under the MDR
- In vitro diagnostic devices regulated under the IVDR
The Authorised Representative must be formally appointed through a written mandate and has specific legal responsibilities. These include verifying that EU declarations of conformity exist, making sure technical documentation can be provided to authorities when requested, and acting as the main point of contact for regulators.
If an Authorised Representative is required but not appointed, the product cannot legally be placed on the EU market, regardless of its safety or performance.
The UK Dimension: UK Responsible Person
Manufacturers placing devices on the Great Britain market must appoint a UK Responsible Person if they are not established in the UK.
Although the EU and UK regulatory frameworks are still aligned in many respects, they are legally separate systems. Meeting MDR or IVDR requirements does not automatically mean UK requirements are met. As a result, many manufacturers need both an EU Authorised Representative and a UK Responsible Person, especially when supplying products to both EU and UK markets.
Final Takeaway
The question of whether a product is an IVD or a medical device is not just about wording. It is a fundamental compliance decision that affects every stage of the product lifecycle. Identifying and documenting the correct regulatory pathway early on helps avoid costly corrections, delays, and unnecessary rework later. With increasing regulatory scrutiny and limited notified body capacity, manufacturers that take a proactive and well-informed approach to classification and regulatory strategy are far better positioned for success in the EU market.
If you need support determining whether your product falls under the MDR or IVDR, confirming its classification, or meeting EU Authorised Representative or UK Responsible Person requirements, Euverify can help reduce risk and support faster, compliant access to EU and UK markets.
Related Resources
Medical devices
Industry Insights
GDPR
Compliance News & Updates
EPREL
Regulatory Framework
Cosmetics
Industry Insights
Electric Devices
Regulatory Framework
